Cita APA

Montalban Gairín, X., Solari, A., Brochet, B., Langdon, D., Piehl, F., Lechner-Scott, J., & Hupperts, R. (2021). Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis.

Citación estilo Chicago

Montalban Gairín, Xavier, Alessandra Solari, Bruno Brochet, Dawn Langdon, Fredrik Piehl, Jeannette Lechner-Scott, y Raymond Hupperts. Treatment Satisfaction, Safety, and Tolerability of Cladribine Tablets in Patients With Highly Active Relapsing Multiple Sclerosis: CLARIFY-MS Study 6-month Interim Analysis. 2021.

Cita MLA

Montalban Gairín, Xavier, et al. Treatment Satisfaction, Safety, and Tolerability of Cladribine Tablets in Patients With Highly Active Relapsing Multiple Sclerosis: CLARIFY-MS Study 6-month Interim Analysis. 2021.